Brooks Gabriel (CIK 1997809) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-18). Recent activity: Buy SLDB (10,937 shares), Sell SLDB (0 shares), Sell SLDB (12,616 shares), Buy SLDB (58,847 shares), Buy SLDB (28,225 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-18 | Solid Biosciences Inc. (SLDB) | Chief Medical Officer | Buy | 10,937 | $0 |
| 2026-02-18 | Solid Biosciences Inc. (SLDB) | Chief Medical Officer | Sell | 0 | $0 |
| 2026-02-06 | Solid Biosciences Inc. (SLDB) | Chief Medical Officer | Sell | 12,616 | $81,247 |
| 2026-02-02 | Solid Biosciences Inc. (SLDB) | Chief Medical Officer | Buy | 58,847 | $0 |
| 2026-02-02 | Solid Biosciences Inc. (SLDB) | Chief Medical Officer | Buy | 28,225 | $0 |
| 2026-02-02 | Solid Biosciences Inc. (SLDB) | Chief Medical Officer | Sell | 28,335 | $182,477 |
| 2025-10-21 | Solid Biosciences Inc. (SLDB) | Chief Medical Officer | Buy | 9,750 | $0 |
| 2025-10-21 | Solid Biosciences Inc. (SLDB) | Chief Medical Officer | Sell | 2,895 | $17,254 |
| 2025-02-18 | Solid Biosciences Inc. (SLDB) | Chief Medical Officer | Buy | 10,937 | $0 |
| 2025-02-18 | Solid Biosciences Inc. (SLDB) | Chief Medical Officer | Sell | 3,256 | $12,894 |
Source: SEC Form 4 filings · as of 2026-02-18